Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Mersana Therapeutics, Inc. See All Filings	D	2016-06-24 15:30:33 UTC
Amount To Be Raised $33,099,988 Associated Brokers / Dealers N/A CIK Number 0001442836 Filed Document 0001442836-16-000004 Exclusions or Exemptions 506b Accepted Date 2016-06-24 15:30:33 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Mersana Therapeutics, Inc. See All Filings	D/A	2016-03-01 00:00:00 UTC
Amount To Be Raised $35,450,006 Associated Brokers / Dealers N/A CIK Number 0001442836 Filed Document 0001442836-16-000003 Exclusions or Exemptions 506b Accepted Date 2016-03-01 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Mersana Therapeutics, Inc. See All Filings	D	2015-03-03 00:00:00 UTC
Amount To Be Raised $35,450,006 Associated Brokers / Dealers N/A CIK Number 0001442836 Filed Document 0001442836-15-000002 Exclusions or Exemptions 506b Accepted Date 2015-03-03 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
MERSANA THERAPEUTICS INC See All Filings	D/A	2014-04-08 00:00:00 UTC
Amount To Be Raised $14,505,371 Associated Brokers / Dealers N/A CIK Number 0001442836 Filed Document 0001604822-14-000041 Exclusions or Exemptions 506b Accepted Date 2014-04-08 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
MERSANA THERAPEUTICS INC See All Filings	D	2013-10-09 00:00:00 UTC
Amount To Be Raised $14,499,542 Associated Brokers / Dealers N/A CIK Number 0001442836 Filed Document 0001588839-13-000001 Exclusions or Exemptions 506b Accepted Date 2013-10-09 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity